📊 PACS Key Takeaways
Is PACS Group, Inc. (PACS) a Good Investment?
PACS demonstrates strong operational efficiency with 20.2% ROE and robust free cash flow generation of $404.2M, but revenue and earnings stagnation (+0.0% YoY) signal limited organic growth prospects. Tight working capital position (1.07x current ratio) presents liquidity risk in a capital-intensive healthcare sector.
PACS generates solid free cash flow and strong ROE with modest leverage, indicating a resilient operating model in skilled nursing. However, flat revenue and thin margins in a highly regulated, labor‑intensive sector temper growth quality, and EPS outperformance looks disconnected from top-line momentum. Maintain neutrality until consistent top-line growth and margin durability are demonstrated.
Why Buy PACS Group, Inc. Stock? PACS Key Strengths
- Excellent return on equity (20.2%) indicates highly efficient capital deployment and shareholder value creation
- Strong free cash flow generation ($404.2M annually, 7.6% FCF margin) demonstrates consistent cash conversion ability
- Moderate leverage (0.37x Debt/Equity) provides balance sheet flexibility and financial stability for capital-intensive operations
- Robust free cash flow and 7.6% FCF margin
- High ROE (20.2%) with modest leverage (0.37x D/E)
- Low long-term debt relative to assets and positive operating cash flow
PACS Stock Risks: PACS Group, Inc. Investment Risks
- Complete revenue stagnation (0.0% YoY) on $5.3B base indicates market maturity and absence of organic growth drivers
- Critically tight liquidity position (1.07x current ratio) leaves minimal operational buffer for disruptions or strategic investments
- Missing capital expenditure disclosure obscures true free cash flow quality and unmet facility upgrade/maintenance needs in aging care sector
- Flat revenue growth indicates limited demand/pricing momentum
- Thin margins in a reimbursement- and labor-sensitive model
- Tight liquidity (current ratio 1.07x) and unclear interest coverage
Key Metrics to Watch
- Revenue growth rate acceleration - current 0% growth is unsustainable for equity value creation
- Working capital trends and current ratio recovery - liquidity cushion deterioration signals distress risk
- Actual capital expenditure requirements and disclosure - critical to validate reported free cash flow sustainability
- Same-facility revenue growth and occupancy/payer mix
- Operating margin and labor cost ratio
PACS Group, Inc. (PACS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
PACS Group, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
PACS Profit Margin, ROE & Profitability Analysis
PACS vs Services Sector: How PACS Group, Inc. Compares
How PACS Group, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is PACS Group, Inc. Stock Overvalued? PACS Valuation Analysis 2026
Based on fundamental analysis, PACS Group, Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
PACS Group, Inc. Balance Sheet: PACS Debt, Cash & Liquidity
PACS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: PACS Group, Inc.'s revenue has grown significantly by 29% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.88 reflects profitable operations.
PACS Revenue Growth, EPS Growth & YoY Performance
PACS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $1.0B | $15.6M | $0.10 |
| Q2 2025 | $935.3M | $2.9M | $0.02 |
| Q1 2025 | $919.4M | $28.5M | $0.17 |
| Q3 2024 | $788.9M | $15.6M | $0.10 |
| Q2 2024 | $760.4M | -$10.9M | $-0.07 |
| Q1 2024 | $707.8M | $37.6M | $0.29 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
PACS Group, Inc. Dividends, Buybacks & Capital Allocation
PACS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for PACS Group, Inc. (CIK: 0002001184)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| Mar 26, 2026 | 4 | xslF345X06/wk-form4_1774563293.xml | View → |
| Mar 26, 2026 | 4 | xslF345X06/wk-form4_1774563264.xml | View → |
| Mar 26, 2026 | 4 | xslF345X06/wk-form4_1774563220.xml | View → |
| Mar 26, 2026 | 4 | xslF345X06/wk-form4_1774563174.xml | View → |
| Mar 26, 2026 | 4 | xslF345X06/wk-form4_1774563132.xml | View → |
❓ Frequently Asked Questions about PACS
What is the AI rating for PACS?
PACS Group, Inc. (PACS) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 64% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are PACS's key strengths?
Claude: Excellent return on equity (20.2%) indicates highly efficient capital deployment and shareholder value creation. Strong free cash flow generation ($404.2M annually, 7.6% FCF margin) demonstrates consistent cash conversion ability. ChatGPT: Robust free cash flow and 7.6% FCF margin. High ROE (20.2%) with modest leverage (0.37x D/E).
What are the risks of investing in PACS?
Claude: Complete revenue stagnation (0.0% YoY) on $5.3B base indicates market maturity and absence of organic growth drivers. Critically tight liquidity position (1.07x current ratio) leaves minimal operational buffer for disruptions or strategic investments. ChatGPT: Flat revenue growth indicates limited demand/pricing momentum. Thin margins in a reimbursement- and labor-sensitive model.
What is PACS's revenue and growth?
PACS Group, Inc. reported revenue of $5.3B.
Does PACS pay dividends?
PACS Group, Inc. does not currently pay dividends.
Where can I find PACS SEC filings?
Official SEC filings for PACS Group, Inc. (CIK: 0002001184) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PACS's EPS?
PACS Group, Inc. has a diluted EPS of $1.22.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is PACS a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, PACS Group, Inc. has a HOLD rating with 64% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is PACS stock overvalued or undervalued?
Valuation metrics for PACS: ROE of 20.2% (sector avg: 16%), net margin of 3.6% (sector avg: 10%). Higher ROE suggests strong returns relative to peers.
Should I buy PACS stock in 2026?
Our dual AI analysis gives PACS Group, Inc. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PACS's free cash flow?
PACS Group, Inc.'s operating cash flow is $404.2M, with capital expenditures of N/A. FCF margin is 7.6%.
How does PACS compare to other Services stocks?
Vs Services sector averages: Net margin 3.6% (avg: 10%), ROE 20.2% (avg: 16%), current ratio 1.07 (avg: 1.5).